Wedbush Maintains Outperform on Disc Medicine, Lowers Price Target to $88

Disc Medicine, Inc. -3.52% Pre

Disc Medicine, Inc.

IRON

63.85

63.85

-3.52%

0.00% Pre
Wedbush analyst David Nierengarten maintains Disc Medicine (NASDAQ: IRON) with a Outperform and lowers the price target from $110 to $88.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via